We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Cellular Therapies - T Cells - Brexucabtagene autoleucel, cryopreserved - T - Tecartus - Gilead Sciences Pty Ltd - Injection, intravenous infusion - Bag (396794)
ARTG ID 396794
ARTG Name
Cellular Therapies - T Cells - Brexucabtagene autoleucel, cryopreserved - T - Tecartus - Gilead Sciences Pty Ltd - Injection, intravenous infusion - Bag
Product name
T Cells - Brexucabtagene autoleucel, cryopreserved - T - Tecartus
ARTG Date
Registration Type
Biological
Therapeutic good type
Biological
Sponsor
Ingredients
brexucabtagene autoleucel
Licence category
INC
Licence status
A
Licence class
Class 4
Summary
Product information
Consumer medicine information